CLINICAL_TRIALS
trial_result
· 2013-12-02
Clinical Trial Update: Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL [NA]
Summary
A terminated clinical trial evaluating pegylated interferon-alfa 2b in combination with PUVA therapy for lymphoma; results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Lymphoma | NA | Status: TERMINATED | Results posted: 2013-12-02